Is There a Rationale for GnRH Analogue Therapy in Endometriosis?

In: GnRH Analogues in Reproduction and Gynecology · 1990 · pp. 1–6 · doi:10.1007/978-94-009-0721-8_1 · W1596415044
book-chapter OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
AI-generated summary by claude@2026-06+body, 2026-06-07

This paper discusses diagnostic criteria and evaluation of response to medical therapy for endometriosis, a common gynecological disease with controversial pathogenesis and pathophysiology.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-07

This chapter discusses the rationale for GnRH analogue therapy in endometriosis by reviewing criteria used to diagnose endometriosis and to evaluate response to medical therapy, alongside ongoing controversies in the field’s understanding of pathogenesis and pathophysiology. It synthesizes prior evidence and frameworks for assessing therapeutic effects, emphasizing how outcomes are judged in studies of medical treatments. The main limitation is that, as a narrative review/chapter, it does not present new primary clinical data and instead highlights conceptual and methodological issues in evaluating treatments. Relevance to endometriosis: the paper is explicitly about endometriosis and the rationale for GnRH analogue therapy, including how diagnosis and treatment response evaluation criteria are discussed in that context.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (14)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK